Blogging From BIO 2018: Does The Life Science Industry "Get" Cyber Security?

I am attending BIO 2018 in Boston, just steps from our Boston office. Naturally, I was drawn to yesterday's session on "Life Sciences Cyber Exposures and Risk Mitigation Considerations." But I came away disappointed. First of all, the session was held in a small room and even then, it was only one-third full (maybe 30 people of the 16,000 attending BIO 2018 chose to attend).

The session revolved around a recent breach reported by Sangamo Therapeutics. According to the company's recent 8-K:

• "On April 17, 2018, Sangamo Therapeutics, Inc. (the "Company") announced a data security incident involving the compromise of a senior executive's Company email account. Upon learning of the incident on March 28, 2018, external network security experts were promptly engaged, and the incident response team worked diligently to investigate the incident. The Company also promptly notified federal law enforcement of the incident. The investigation concluded that the incident was